Ireland’s weight loss drug-linked exports are plummeting – it’s raising uncomfortable questions

Business Post subscribers can read:

• How Irish peptide exports are plummeting, hitting a potential six-year low

• Which pharma company is linked to such exports

• What the phenomenon has to do with Ireland’s tax base

Ireland’s exports of pharmaceuticals central to the production of blockbuster weight-loss drugs have dipped dramatically after surging to record highs last year.

Exports of protein and peptide-based hormones – widely understood to relate specifically to Eli Lilly’s operations in Ireland – are on track to hit a six-year low in 2026, according to US trade data analysed by the Business Post.